Chorioretinitis: Clinical Trials

14 trials for Chorioretinitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 unknown, 2 recruiting, 1 withdrawn. 2 Not applicable, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 22Completed 2
Phase 32Completed 1, Unknown 1

Follow Chorioretinitis: new trials by email Literature Review of Chorioretinitis trials Research Report on Chorioretinitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Anterior Uveitis (AU), Birdshot Chorioretinitis
RecruitingOregon Health and Science University1252024-09-012025-07-17
Pregnancy and Congenital Toxoplasmosis
Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. - Congenital Toxoplasmosis, Retinochoroiditis
CompletedHospices Civils de Lyon762023-05-102026-01-22
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
Companion blood samples with procedure - Autoimmune Diseases, Ulcerative Colitis
CompletedTScan Therapeutics, Inc.2382023-01-032026-09-15
Ocular Changes in Vitiligo Patients on Therapy
Optical coherence tomography angiography (OCT-A) - Vitiligo, Chorioretinopathy
UnknownBenha University1002022-03-102022-04-19
SD-OCT Guided Treatment of Fungal Chorioretinitis
Fluconazole 150 mg - Fungal Retinitis
UnknownBenha University102020-01-152021-12-15
Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis
Intravitreal injection, Fluorescent angiography, Visometry - Chorioretinitis
Not applicableUnknownThe Filatov Institute of Eye Diseases and Tissue Therapy1002018-03-272021-02-03
Ocular Manifestations in Rheumatic Diseases
No intervention used - Uveitis, Conjunctivitis
CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's50002013-05-012022-04-12
Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis
Trimethoprim-Sulfamethoxazole - Ocular Toxoplasmosis
Phase 3CompletedUniversity of Campinas, Brazil1412011-10-012016-07-12
Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.
Hearing Loss, Mental Retardation
WithdrawnOslo University Hospital2010-08-012022-09-23
Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
Fluorescein angiography, Dilated fundus examination, Toxoplasmosis serology - Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection
Not applicableCompletedUniversity Hospital, Grenoble722010-01-012016-07-25
Safety and Efficacy of AIN457 in Noninfectious Uveitis
AIN457, AIN 457 - Non-infectious Uveitis
Phase 2CompletedNovartis Pharmaceuticals762008-06-012017-07-17
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
interferon alpha 2a, prednisone - Birdshot Chorioretinopathy, Cystoid Macular Edema
Phase 2CompletedAssistance Publique - Hôpitaux de Paris582007-09-012013-01-23
To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
pyrimethamine-sulfadiazine + prednisolone, Clindamycin+Dexamethasone - Chorioretinitis
Phase 3UnknownShahid Beheshti University of Medical Sciences2005-07-012008-07-30
Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD)
Observational study - Birdshot Chorioretinopathy, Posterior Uveitis
RecruitingAssistance Publique - Hôpitaux de Paris6002004-11-022026-03-04

Narrower conditions

Birdshot Chorioretinopathy (5)  ·  Uveitis (3)  ·  Behcet Syndrome (2)  ·  Macular Edema (2)  ·  Sarcoidosis (2)  ·  Toxoplasmosis (2)  ·  Uveitis, Posterior (2)  ·  Amaurosis Fugax (1)  ·  Arthritis, Juvenile (1)  ·  Autoimmune Diseases (1)  ·  Blindness (1)  ·  Celiac Disease (1)  ·  Choroid Hemorrhage (1)  ·  Choroidal Neovascularization (1)

Broader conditions

Choroid Diseases (14)  ·  Choroiditis (14)  ·  Eye Diseases (14)  ·  Retinal Diseases (14)  ·  Uveal Diseases (14)  ·  Panuveitis (13)  ·  Retinitis (13)  ·  Uveitis, Posterior (12)  ·  Uveitis (11)  ·  Immune System Diseases (5)  ·  White Dot Syndromes (5)  ·  Autoimmune Diseases (4)  ·  Coccidiosis (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)

Interventions

Fluconazole (1)  ·  Fluorescein Angiography (1)  ·  Interferon alpha-2 (1)  ·  Intravitreal Injections (1)  ·  Observation (1)  ·  Ophthalmoscopy (1)  ·  Postpartum Period (1)  ·  Prednisolone (1)  ·  Prednisone (1)  ·  Punctures (1)  ·  Slit Lamp Microscopy (1)  ·  Sulfamethoxazole (1)  ·  Trimethoprim (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  secukinumab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Benha University (2)  ·  Hospices Civils de Lyon (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Novartis Pharmaceuticals (1)  ·  Oregon Health and Science University (1)  ·  Oslo University Hospital (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  TScan Therapeutics, Inc. (1)  ·  The Filatov Institute of Eye Diseases and Tissue Therapy (1)  ·  University Hospital, Grenoble (1)  ·  University of Campinas, Brazil (1)

Countries

France (4)  ·  United States (3)  ·  Brazil (1)  ·  Egypt (1)  ·  Germany (1)  ·  Iran (1)  ·  Norway (1)  ·  Ukraine (1)  ·  United Arab Emirates (1)

Top investigators

Amal A Yousif, MD (1)  ·  Andrii MD Korol, PhD (1)  ·  Janet Pope, MD (1)  ·  Laurence Bouillet, Professor (1)  ·  Martine Wallon (1)  ·  Masoud Soheilian, MD (1)  ·  Rodrigo PC Lira, PhD (1)  ·  Yan Li, PhD (1)

Results publications

PMID 12095806, PMID 15079763, PMID 20926833, PMID 25638011, PMID 37204866, PMID 39250617, PMID 40010761

NIH funding

R21EY036563 (1)